Sensei Biotherapeutics Correlations
SNSE Stock | USD 0.49 0.03 6.52% |
The current 90-days correlation between Sensei Biotherapeutics and Evaxion Biotech AS is 0.06 (i.e., Significant diversification). The correlation of Sensei Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Sensei Biotherapeutics Correlation With Market
Significant diversification
The correlation between Sensei Biotherapeutics and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sensei Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.
Sensei |
Moving together with Sensei Stock
Moving against Sensei Stock
0.72 | PG | Procter Gamble | PairCorr |
0.47 | WM | Waste Management | PairCorr |
0.45 | LUCD | Lucid Diagnostics | PairCorr |
0.57 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.57 | T | ATT Inc Sell-off Trend | PairCorr |
0.49 | IBM | International Business | PairCorr |
0.33 | DD | Dupont De Nemours | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sensei Stock performing well and Sensei Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sensei Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LABP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
VOR | 5.37 | 0.10 | 0.04 | (0.10) | 5.18 | 16.79 | 63.37 | |||
EVAX | 7.76 | (0.74) | 0.00 | 15.24 | 0.00 | 25.30 | 92.83 | |||
DBTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NEXI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sensei Biotherapeutics Corporate Management
Edward Horst | Chief Officer | Profile | |
Christopher JD | VP Counsel | Profile | |
Elisabeth Colunio | VP HR | Profile | |
Lora Pike | Vice Communications | Profile | |
Steven Fuller | Chief Officer | Profile | |
Robert MD | Chief Officer | Profile | |
Erin Colgan | Chief Officer | Profile |